| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V93640 | AMG133 peptide payload | The AMG133 peptide payload is a GLP-1 agonist and can be used as a peptide linker conjugate of AMG133. | |
|
V33194 | Avexitide | 133514-43-9 | Avexitide [Exendin-3 (9-39)] is a novel, competitive and peptidic antagonist of glucagon-like peptide-1 (GLP-1) receptor with a Kd of 1.7 nM at cloned human GLP-1 receptors. |
|
V51719 | Bay 55-9837 | 463930-25-8 | VPAC2 agonist |
|
V133157 | DA-302168S | 2969158-02-7 | DA-302168S is an orally effective selective GLP-1 receptor agonist with an EC50 value of 1.32 nM. |
|
V74595 | Exendin (5-39) | 196109-27-0 | Exendin (5-39) is a potent glucagon-like peptide 1 (GLP-1 receptor) receptor antagonist. |
|
V79393 | FC382K10W15 TFA | FC382K10W15 TFA is a glucagon analog and GLP-1R/GCGR agonist. | |
|
V74588 | GIP/GLP-1 dual receptor agonist-1 | 2807481-02-1 | GIP/GLP-1 dual receptor agonist-1 (compound 4) is a GIP/GLP-1 dual receptor agonist. |
|
V74591 | GLP-1 receptor agonist 3 | 2230200-09-4 | GLP-1 receptor agonist 3 (compound (R)-4A-1) is a potent and specific GLP-1 receptor agonist (WO2018109607A1) that may be utilized in diabetes research. |
|
V74569 | GLP-1(28-36)amide | 1225021-13-5 | GLP-1(28-36)amide is a C-terminal nonapeptide of GLP-1 and is the main product of GLP-1 cleavage by a neutral endopeptidase (NEP). |
|
V76974 | GLP-1(7-36), amide TFA (Glucagon-like peptide-1 (GLP-1)(7-36), amide TFA; Human GLP-1 (7-36), amide TFA) | GLP-1(7-36), amide TFA is a major intestinal hormone that prompts pancreatic beta cells to secrete insulin when stimulated by glucose. | |
|
V74567 | GLP-1Ragonist 2 | 281209-71-0 | GLP-1R agonist 2 (compound 2) is a potent GLP-1R agonist. |
|
V136714 | Glucagon receptor antagonist inactive control | 362482-00-6 | Glucagon receptor antagonist inactive control is a compound with a structure similar to glucagon receptor (GCGR) antagonist (compound 1), but lacks antagonistic activity against glucagon receptor (GCGR). |
|
V2961 | LGD-6972 | 1207989-09-0 | LGD-6972 (LGD6972; MB-11262) is a novel and orally bioavailable glucagon receptor antagonist with the potential to be used for treating type 2 diabetes (T2DM). |
|
V74561 | Mazdutide (IBI-362; LY-3305677; OXM-3) | 2259884-03-0 | Mazdutide (IBI-362; LY-3305677) is a long-acting synthetic oxyntomodulin analog. |
|
V81023 | Oxyntomodulin (bovine, porcine) (TFA) (Glucagon-37 (bovine, porcine) (TFA)) | Oxyntomodulin (bovine, porcine) TFA is a 37-amino-acid peptide hormone that is a glucagon-like peptide 1 (GLP-1) receptor agonist. | |
|
V101594 | Semaglutide, FITC labeled | Semaglutide is FITC-labeled semaglutide. | |
|
V145462 | Survodutide TFA | Survodutide TFA is a potent and selective dual agonist of glucagon receptor/GLP-1 receptor (GCGR/GLP-1R) with EC50 values of 0.52 nM and 0.33 nM in CHO-K1 cells, respectively. | |
|
V146321 | TP-α | 1708978-54-4 | TP-α is a selective two-photon fluorescent probe for glucagon with a dissociation constant (Kd) of 65 μM. |
|
V146307 | TPM003 | TPM003 is a triple agonist of GLP-1R, GIPR and GCGR, with EC50 values of 33.9 pM, 12.5 pM and 92.9 pM, respectively. | |
|
V147313 | Zenagamtide sodium | Zenagamtide sodium is an orally effective, blood-brain barrier-crossing triple agonist that targets GLP-1, amylin (amylin receptor), and calcitonin receptor (calcitonin receptor). |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
